Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Flowers, Lisa C.

Emory University
United States

Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH) 5UG1CA284884-03 Maria Silvina Frech, Ph.D., M.S.
Flowers, Lisa C.

Emory University
United States

Screening Strategies Among High-Risk Populations for Anal Cancer 5R01CA285198-03 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Flynn, Kathryn E

Medical College Of Wisconsin
United States

Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM) 5R01CA285925-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Freedland, Stephen Jay

Cedars-Sinai Medical Center
United States

Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes 3R01CA280081-03S1 Young Kim, Ph.D.
Fuschiotti, Patrizia

University Of Pittsburgh At Pittsburgh
United States

Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides 5R21CA280445-02 Wendy Wang, Ph.D., M.Sc.
Garcia, Jose M.

Seattle Inst For Biomedical/Clinical Res
United States

SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) 5R01CA279220-03 Marjorie Perloff, M.D.
Geisler, Stefanie

Washington University
United States

Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy 5R37CA267905-05 Asad Umar, D.V.M., Ph.D.
Germain, Doris A

Icahn School Of Medicine At Mount Sinai
United States

Investigating the efficacy of g-Tocotrienol for the prevention of post-partum breast cancer 1R01CA301372-01 Anda Vlad, M.D., Ph.D.
Ghobrial, Irene M.

Dana-Farber Cancer Inst
United States

Myeloma multidimensional precancer atlas 4U01CA294507-02 Nicholas Hodges, Ph.D.
Ghobrial, Irene M.

Dana-Farber Cancer Inst
United States

Molecular prediction of myeloma in African Americans 5U01CA271492-04 PAR-18-913 (U01 Clinical Trial Not Allowed) Claire Zhu, Ph.D.